Gastroparesis Diagnostic Study of Choice
Gastroparesis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gastroparesis Diagnostic Study of Choice On the Web |
American Roentgen Ray Society Images of Gastroparesis Diagnostic Study of Choice |
Risk calculators and risk factors for Gastroparesis Diagnostic Study of Choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]; Madhu Sigdel M.B.B.S.[3]
Overview
Gastric emptying scintigraphy is considered a gold standard diagnostic test for gastroparesis. Delayed gastric emptying is confirmed by 10% gastric retention at 4 hours. Factors that affect the results of this test include medications, tobacco smoking, and hyperglycemia.
Diagnostic Study of Choice
- Gastric emptying scintigraphy is considered a gold standard diagnostic test for gastroparesis.[1][2][3][4]
- The method for this test is eating a low-fat, egg-white meal followed by repeated scans to measure the rate of gastric emptying at 0, 1, 2, and 4 hours.
- The delayed gastric emptying would be confirmed, if there is:
- The advantages of gastric emptying scintigraphy include:
- Noninvasive
- Quantitative
- High sensitivity
- High specificity
References
- ↑ Tang, Derek M.; Friedenberg, Frank K. (2011). "Gastroparesis: Approach, Diagnostic Evaluation, and Management". Disease-a-Month. 57 (2): 74–101. doi:10.1016/j.disamonth.2010.12.007. ISSN 0011-5029.
- ↑ Koch, Kenneth L.; Calles-Escandón, Jorge (2015). "Diabetic Gastroparesis". Gastroenterology Clinics of North America. 44 (1): 39–57. doi:10.1016/j.gtc.2014.11.005. ISSN 0889-8553.
- ↑ Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH; et al. (2008). "Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine". Am J Gastroenterol. 103 (3): 753–63. doi:10.1111/j.1572-0241.2007.01636.x. PMID 18028513.
- ↑ Waseem S, Moshiree B, Draganov PV (2009). "Gastroparesis: current diagnostic challenges and management considerations". World J Gastroenterol. 15 (1): 25–37. PMC 2653292. PMID 19115465.